Literature DB >> 27661440

Medication-induced acute kidney injury.

Stuart L Goldstein1.   

Abstract

PURPOSE OF REVIEW: The present article will review the current state of our understanding of nephrotoxic medication-associated acute kidney injury (AKI) and provide strategies to reduce its impact. RECENT
FINDINGS: Nephrotoxic medications contribute to a substantial proportion of AKI in hospitalized patients. The previous perspective of nephrotoxic medication-associated AKI as a nonmodifiable necessary evil of providing appropriate therapy to ill patients had led to an incomplete understanding of its epidemiology and provided little impetus to reduce its occurrence.
SUMMARY: Recent work on understanding specific combinations, thresholds for nephrotoxic burden and systematic kidney function assessment had mitigated, and even in some cases reduced, nephrotoxic AKI rates and severity. Current initiatives are underway to further refine specific nephrotoxic medication AKI risk via novel urinary biomarkers and genetic susceptibility.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27661440     DOI: 10.1097/MCC.0000000000000355

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  7 in total

1.  Use of height-independent baseline creatinine imputation method with renal angina index.

Authors:  Jean-Philippe Roy; Catherine Johnson; Bryan Towne; Frank Menke; Samuel Kiger; William Young; Rajit Basu; Ranjit Chima; Lin Fei; Kelli Krallman; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2019-07-08       Impact factor: 3.714

2.  Survival and recovery modeling of acute kidney injury in critically ill adults.

Authors:  Todd N Brothers; Jacob Strock; Traci J LeMasters; Jayne Pawasauskas; Ronald C Reed; Mohammad A Al-Mamun
Journal:  SAGE Open Med       Date:  2022-05-26

3.  Impact of acute kidney injury and nephrotoxic exposure on hospital length of stay.

Authors:  Justin B Searns; Katja M Gist; John T Brinton; Kaci Pickett; James Todd; Meghan Birkholz; Danielle E Soranno
Journal:  Pediatr Nephrol       Date:  2020-01-15       Impact factor: 3.714

4.  Incidence and impact of acute kidney injury on patients with implantable left ventricular assist devices: a Meta-analysis.

Authors:  Charat Thongprayoon; Ploypin Lertjitbanjong; Wisit Cheungpasitporn; Panupong Hansrivijit; Tibor Fülöp; Karthik Kovvuru; Swetha R Kanduri; Paul W Davis; Saraschandra Vallabhajosyula; Tarun Bathini; Kanramon Watthanasuntorn; Narut Prasitlumkum; Ronpichai Chokesuwattanaskul; Supawat Ratanapo; Michael A Mao; Kianoush Kashani
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

5.  Patients with Different Stages of Chronic Kidney Disease Undergoing Intravenous Contrast-Enhanced Computed Tomography-The Incidence of Contrast-Associated Acute Kidney Injury.

Authors:  Ming-Ju Wu; Shang-Feng Tsai
Journal:  Diagnostics (Basel)       Date:  2022-03-30

6.  Oridonin Attenuates Cisplatin-Induced Acute Kidney Injury via Inhibiting Oxidative Stress, Apoptosis, and Inflammation in Mice.

Authors:  Hyemin Gu; Mi-Gyeong Gwon; Jong Hyun Kim; Jaechan Leem; Sun-Jae Lee
Journal:  Biomed Res Int       Date:  2022-04-16       Impact factor: 3.246

7.  Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury.

Authors:  Stephan Ehrmann; Julie Helms; Aurélie Joret; Laurent Martin-Lefevre; Jean-Pierre Quenot; Jean-Etienne Herbrecht; Dalila Benzekri-Lefevre; René Robert; Arnaud Desachy; Fréderic Bellec; Gaëtan Plantefeve; Anne Bretagnol; Auguste Dargent; Jean-Claude Lacherade; Ferhat Meziani; Bruno Giraudeau; Elsa Tavernier; Pierre-François Dequin
Journal:  Ann Intensive Care       Date:  2019-09-23       Impact factor: 6.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.